207 related articles for article (PubMed ID: 24863058)
1. Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.
Imbrici P; Liantonio A; Gradogna A; Pusch M; Camerino DC
Biochim Biophys Acta; 2014 Oct; 1838(10):2484-91. PubMed ID: 24863058
[TBL] [Abstract][Full Text] [Related]
2. Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.
Zifarelli G; Liantonio A; Gradogna A; Picollo A; Gramegna G; De Bellis M; Murgia AR; Babini E; Camerino DC; Pusch M
Br J Pharmacol; 2010 Aug; 160(7):1652-61. PubMed ID: 20649569
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels.
Picollo A; Liantonio A; Babini E; Camerino DC; Pusch M
J Membr Biol; 2007 Apr; 216(2-3):73-82. PubMed ID: 17659402
[TBL] [Abstract][Full Text] [Related]
4. I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes.
Gradogna A; Imbrici P; Zifarelli G; Liantonio A; Camerino DC; Pusch M
Biochim Biophys Acta; 2014 Nov; 1838(11):2745-56. PubMed ID: 25073071
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the mouse ClC-K1/Barttin chloride channel.
L'Hoste S; Diakov A; Andrini O; Genete M; Pinelli L; Grand T; Keck M; Paulais M; Beck L; Korbmacher C; Teulon J; Lourdel S
Biochim Biophys Acta; 2013 Nov; 1828(11):2399-409. PubMed ID: 23791703
[TBL] [Abstract][Full Text] [Related]
6. Activation and inhibition of kidney CLC-K chloride channels by fenamates.
Liantonio A; Picollo A; Babini E; Carbonara G; Fracchiolla G; Loiodice F; Tortorella V; Pusch M; Camerino DC
Mol Pharmacol; 2006 Jan; 69(1):165-73. PubMed ID: 16244177
[TBL] [Abstract][Full Text] [Related]
7. Barttin increases surface expression and changes current properties of ClC-K channels.
Waldegger S; Jeck N; Barth P; Peters M; Vitzthum H; Wolf K; Kurtz A; Konrad M; Seyberth HW
Pflugers Arch; 2002 Jun; 444(3):411-8. PubMed ID: 12111250
[TBL] [Abstract][Full Text] [Related]
8. Activation of renal ClC-K chloride channels depends on an intact N terminus of their accessory subunit barttin.
Wojciechowski D; Thiemann S; Schaal C; Rahtz A; de la Roche J; Begemann B; Becher T; Fischer M
J Biol Chem; 2018 Jun; 293(22):8626-8637. PubMed ID: 29674316
[TBL] [Abstract][Full Text] [Related]
9. Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms.
Liantonio A; Imbrici P; Camerino GM; Fracchiolla G; Carbonara G; Giannico D; Gradogna A; Mangiatordi GF; Nicolotti O; Tricarico D; Pusch M; Camerino DC
J Hypertens; 2016 May; 34(5):981-92. PubMed ID: 26991533
[TBL] [Abstract][Full Text] [Related]
10. Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers.
Liantonio A; Pusch M; Picollo A; Guida P; De Luca A; Pierno S; Fracchiolla G; Loiodice F; Tortorella P; Conte Camerino D
J Am Soc Nephrol; 2004 Jan; 15(1):13-20. PubMed ID: 14694153
[TBL] [Abstract][Full Text] [Related]
11. A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.
Gradogna A; Babini E; Picollo A; Pusch M
J Gen Physiol; 2010 Sep; 136(3):311-23. PubMed ID: 20805576
[TBL] [Abstract][Full Text] [Related]
12. Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.
Liantonio A; Picollo A; Carbonara G; Fracchiolla G; Tortorella P; Loiodice F; Laghezza A; Babini E; Zifarelli G; Pusch M; Camerino DC
Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1369-73. PubMed ID: 18216243
[TBL] [Abstract][Full Text] [Related]
13. Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.
Liantonio A; Giannuzzi V; Picollo A; Babini E; Pusch M; Conte Camerino D
Br J Pharmacol; 2007 Jan; 150(2):235-47. PubMed ID: 17128287
[TBL] [Abstract][Full Text] [Related]
14. Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional.
Steinke KV; Gorinski N; Wojciechowski D; Todorov V; Guseva D; Ponimaskin E; Fahlke C; Fischer M
J Biol Chem; 2015 Jul; 290(28):17390-400. PubMed ID: 26013830
[TBL] [Abstract][Full Text] [Related]
15. Novel CLCNKB mutations causing Bartter syndrome affect channel surface expression.
Keck M; Andrini O; Lahuna O; Burgos J; Cid LP; Sepúlveda FV; L'hoste S; Blanchard A; Vargas-Poussou R; Lourdel S; Teulon J
Hum Mutat; 2013 Sep; 34(9):1269-78. PubMed ID: 23703872
[TBL] [Abstract][Full Text] [Related]
16. Role of zebrafish ClC-K/barttin channels in apical kidney chloride reabsorption.
Pérez-Rius C; Castellanos A; Gaitán-Peñas H; Navarro A; Artuch R; Barrallo-Gimeno A; Estévez R
J Physiol; 2019 Aug; 597(15):3969-3983. PubMed ID: 31177533
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pharmacology of Kidney and Inner Ear CLC-K Chloride Channels.
Gradogna A; Pusch M
Front Pharmacol; 2010; 1():130. PubMed ID: 21833170
[TBL] [Abstract][Full Text] [Related]
18. Carboxyl-terminal Truncations of ClC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking.
Stölting G; Bungert-Plümke S; Franzen A; Fahlke C
J Biol Chem; 2015 Dec; 290(51):30406-16. PubMed ID: 26453302
[TBL] [Abstract][Full Text] [Related]
19. DHHC7-mediated palmitoylation of the accessory protein barttin critically regulates the functions of ClC-K chloride channels.
Gorinski N; Wojciechowski D; Guseva D; Abdel Galil D; Mueller FE; Wirth A; Thiemann S; Zeug A; Schmidt S; Zareba-Kozioł M; Wlodarczyk J; Skryabin BV; Glage S; Fischer M; Al-Samir S; Kerkenberg N; Hohoff C; Zhang W; Endeward V; Ponimaskin E
J Biol Chem; 2020 May; 295(18):5970-5983. PubMed ID: 32184353
[TBL] [Abstract][Full Text] [Related]
20. Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.
Estévez R; Boettger T; Stein V; Birkenhäger R; Otto E; Hildebrandt F; Jentsch TJ
Nature; 2001 Nov; 414(6863):558-61. PubMed ID: 11734858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]